Literature DB >> 9374435

Influence of ionizing radiation on proliferation, c-myc expression and the induction of apoptotic cell death in two breast tumour cell lines differing in p53 status.

N C Watson1, Y M Di, M S Orr, F A Fornari, J K Randolph, K J Magnet, P T Jain, D A Gewirtz.   

Abstract

PURPOSE: To determine the capacity of ionizing radiation to inhibit proliferation, to suppress c-myc expression and to induce apoptotic cell death in the p53 wild-type MCF-7 cell line and the p53 mutated MDA-MB231 cell line.
MATERIALS AND METHODS: Growth inhibition and cell killing were determined by cell number and trypan blue exclusion. Apoptosis was assessed through cell morphology and fluorescent end-labelling. c-myc expression was monitored by Northern blotting.
RESULTS: Inhibition of cell proliferation by ionizing radiation was similar in both cell lines. MDA-MB231 cells accumulated in G2 while MCF-7 cells accumulated in both the G1 and G2 phases of the cell cycle after irradiation. There was no evidence of apoptosis in either cell line. In MCF-7 cells, growth inhibition correlated closely with an early dose-dependent suppression of c-myc expression; in MDA-MB231 cells, there was no correspondence between growth inhibition and a transient, dose-independent reduction in c-myc message.
CONCLUSIONS: These findings suggest that in the absence of classical apoptotic cell death, radiosensitivity is not predictably related to the p53 status of the cell. While both p53 and c-myc may be linked to the DNA damage response pathway, neither p53 nor c-myc are essential for growth arrest in response to ionizing radiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374435     DOI: 10.1080/095530097143059

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  8 in total

1.  Comparison of methods based on annexin-V binding, DNA content or TUNEL for evaluating cell death in HL-60 and adherent MCF-7 cells.

Authors:  G Del Bino; Z Darzynkiewicz; C Degraef; R Mosselmans; D Fokan; P Galand
Journal:  Cell Prolif       Date:  1999-02       Impact factor: 6.831

2.  Investigation on Semecarpus Lehyam--a Siddha medicine for breast cancer.

Authors:  Srinivasan Sowmyalakshmi; Mohammad Nur-E-Alam; Mohammed A Akbarsha; Subbiah Thirugnanam; Jürgen Rohr; Damodaran Chendil
Journal:  Planta       Date:  2004-10-28       Impact factor: 4.116

Review 3.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

4.  Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: Evidence for an essential role of reactive oxygen species.

Authors:  Supachai Yodkeeree; Bokyung Sung; Pornngarm Limtrakul; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

5.  RAC1 GTPase plays an important role in γ-irradiation induced G2/M checkpoint activation.

Authors:  Ying Yan; Patrick M Greer; Phu T Cao; Ryan H Kolb; Kenneth H Cowan
Journal:  Breast Cancer Res       Date:  2012-04-11       Impact factor: 6.466

6.  Auger Electrons Constructed Active Sites on Nanocatalysts for Catalytic Internal Radiotherapy.

Authors:  Weiwei Su; Han Wang; Tao Wang; Xiao Li; Zhongmin Tang; Shuai Zhao; Meng Zhang; Danni Li; Xingwu Jiang; Teng Gong; Wei Yang; Changjing Zuo; Yelin Wu; Wenbo Bu
Journal:  Adv Sci (Weinh)       Date:  2020-04-06       Impact factor: 16.806

7.  iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data.

Authors:  Steven Xijin Ge; Eun Wo Son; Runan Yao
Journal:  BMC Bioinformatics       Date:  2018-12-19       Impact factor: 3.169

8.  Ailanthone induces autophagic and apoptotic cell death in human promyelocytic leukemia HL-60 cells.

Authors:  Cheng Wei; Chuanrong Chen; Yuxin Cheng; Lin Zhu; Yu Wang; Can Luo; Yang He; Zhiming Yang; Zhaoning Ji
Journal:  Oncol Lett       Date:  2018-07-06       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.